Australian Clinical Labs Limited's (ASX:ACL) investors are due to receive a payment of A$0.035 per share on 16th of April. This will take the annual payment to 3.9% of the stock price, which is above ...

Australian Clinical Labs (ASX:ACL) has had a rough week with its share price down 4.2%. However, stock prices are usually driven by a company’s financial performance over the long term, which in this ...

A cyberterror expert has questioned why a pathology giant waited five months to inform patients of a data breach that saw credit card and health records leaked. On ...

The Medical Scientists Association of Victoria – a branch of the Health Services Union which represents pathology workers – is concerned ACL will embark on a mass staffing cull as part of its plan to ...

Australian Clinical Labs Ltd ( ($AU:ACL) ) has provided an announcement. Australian Clinical Labs Limited has cancelled 200,000 fully paid ...

Australian Clinical Labs Ltd. Annual stock financials by MarketWatch. View the latest ACL financial statements, income statements and financial ratios.

Australian Clinical Labs ( ASX:ACL ) First Half 2025 Results Key Financial Results Revenue: AU$369.2m (up 9.5% from 1H... Australian Clinical Labs Limited's ( ASX:ACL ) investors are due to receive a ...

Diagnostic testing company Australian Clinical Labs is likely to face the competition watchdog’s ire over its proposed merger with beleaguered larger rival Healius to become the biggest pathology ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.

Key Insights Significantly high institutional ownership implies Australian Clinical Labs' stock price is sensitive to... Australian Clinical Labs Limited ( ASX:ACL ...